| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/03/2009 | WO2009106419A1 New macrolides and their use |
| 09/03/2009 | WO2009106339A1 A method for restoring bmp-receptor signaling in a cell |
| 09/03/2009 | WO2009106307A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 09/03/2009 | WO2009106302A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 09/03/2009 | WO2009106263A1 Use of hypericum perforatum extracts in the treatment of neuropathic pain |
| 09/03/2009 | WO2009105887A1 Cyclic amino acids for the treatment of pain |
| 09/03/2009 | WO2009086163A3 Thiazolylidine urea and amide derivatives and methods of use thereof |
| 09/03/2009 | WO2009081246A3 Bicyclic diamines as nicotinic receptor agonists |
| 09/03/2009 | WO2009062676A3 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 09/03/2009 | WO2009056990A3 Paliperidone polymorphs |
| 09/03/2009 | WO2009052075A3 Method of treating motor disorders with alpha-2b adrenergic receptor agonists |
| 09/03/2009 | WO2009049742A3 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 09/03/2009 | WO2009048537A3 Humanized antibody |
| 09/03/2009 | WO2009046829A3 Casoxin d as a therapeutic agent |
| 09/03/2009 | WO2009043480A3 Use of leptin (22-56 ) as a therapeutic agent |
| 09/03/2009 | WO2009043469A3 Use of pneumadin as a therapeutic agent |
| 09/03/2009 | WO2009040018A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009040017A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009039993A3 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039992A3 Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039988A3 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection |
| 09/03/2009 | WO2009033805A3 Use of somatostatin-14 as a therapeutic agent |
| 09/03/2009 | WO2009033802A3 Antide as a therapeutic agent |
| 09/03/2009 | WO2009033801A3 Syndyphalin alone or in combination with antide as a therapeutic agent |
| 09/03/2009 | WO2009033755A3 Use of l-carnosine as a therapeutic agent |
| 09/03/2009 | WO2009033741A3 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 09/03/2009 | WO2009033737A3 Use of gluten exorphin c : as a therapeutic agent |
| 09/03/2009 | WO2009033731A3 Use of a laminin peptide as a therapeutic agent |
| 09/03/2009 | WO2009033723A3 Use of aip2 as a therapeutic agent |
| 09/03/2009 | WO2009033714A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009033692A3 Use of the peptides fibrinopeptide a and pyx-i as a therapeutic agents |
| 09/03/2009 | WO2009033665A3 Use of a rgd-peptide and/or parathyroid hormone (1-34 ) as anti-hiv agent |
| 09/03/2009 | WO2009033656A3 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection |
| 09/03/2009 | US20090221821 Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2009 | US20090221714 Pharmaceutical Composition for Prevention and Treatment of Drug or Alcohol Addiction or Bipolar Disorder Using Sodium Phenylbutyrate |
| 09/03/2009 | US20090221712 Mandelic hydrazides |
| 09/03/2009 | US20090221711 Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors |
| 09/03/2009 | US20090221707 Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained |
| 09/03/2009 | US20090221706 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 09/03/2009 | US20090221703 High penetration composition and uses thereof |
| 09/03/2009 | US20090221700 Carisprodol Articles and Methods |
| 09/03/2009 | US20090221687 Tetracyclic Monoamine Reuptake Inhibitors for Treatment of Cns Diseases and Disorders |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221661 Phosphodiesterase 4 inhibitors |
| 09/03/2009 | US20090221659 Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 09/03/2009 | US20090221657 Compounds, Compositions Containing Them, Preparation Thereof and Uses Thereof I |
| 09/03/2009 | US20090221651 Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damage |
| 09/03/2009 | US20090221648 Compositions for treatment of cognitive disorders |
| 09/03/2009 | US20090221647 N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors |
| 09/03/2009 | US20090221643 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia |
| 09/03/2009 | US20090221641 Diaza-spiro--nonane derivatives as neurokinin (nk1) antagonists |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221623 Indole Alkaloid Derivatives Having Opioid Receptor Agonistic Effect, and Therapeutic Compositions and Methods Relating to Same |
| 09/03/2009 | US20090221621 Methods of Reducing Alcohol-Induced Dose Dumping for Opioid Sustained Release Oral Dosage Forms |
| 09/03/2009 | US20090221620 Gentic polymorphisms associated with stroke, methods of detection and uses thereof |
| 09/03/2009 | US20090221610 Compositions and Methods for Treating Cognitive Disorders |
| 09/03/2009 | US20090221603 Heterocyclic amide derivatives as calcium channel blockers |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221579 Substituted Amino-Compounds and Uses Thereof |
| 09/03/2009 | US20090221569 Use of lhrh antagonists for intermittent treatments |
| 09/03/2009 | US20090221567 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177 |
| 09/03/2009 | US20090221566 Inhibitors of phosphodiesterase type-iv |
| 09/03/2009 | US20090221554 Method of treating cognitive impairment |
| 09/03/2009 | US20090221552 Methods for the Treatment of ADHD and Related Disorders |
| 09/03/2009 | US20090221548 Melanin concentrating hormone receptor-1 antagonists |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090221535 2-(2,5-Dioxo-5,6-dihydro-4H-imidazo[1,5,4-de]quinoxalin-1(2H)-yl)-N-(3-methyl-spiro[imidazolidine-4,2'-indane]-2,5-dione)acetamide, used as Calcitonin Gene-Related Peptide (CGRP), ligands useful in the treatment or prevention of headaches |
| 09/03/2009 | US20090221534 Cox2 Inhibitor |
| 09/03/2009 | US20090221531 Novel phytic citrate compounds and process for preparing the same |
| 09/03/2009 | US20090221521 Systemic purine administration: modulating axonal outgrowth of central nervous system neurons |
| 09/03/2009 | US20090221513 Treatment of Neurodegenerative Disorders |
| 09/03/2009 | US20090221507 administering peptide sequence tyr-ser-met-lys-lys-thr-thr-met-lys-ile-ile-pro-phe-asn-arg-leu-thr-ile-gly to a mammal to treat degenerative disorder of the nervous system involves leakage of fibrinogen perivascularly in the brain; multiple sclerosis, spinal cord injury, stroke and Alzheimer's Disease |
| 09/03/2009 | US20090221506 Gdnf derived peptides |
| 09/03/2009 | US20090221484 Use of Factor VII Polypeptides for Neuroprotection |
| 09/03/2009 | US20090221479 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth |
| 09/03/2009 | US20090221469 Use of soy kefir powder for reducing pain, blood pressure and inflammation |
| 09/03/2009 | US20090220626 Grape seed extract and its constituents for use as cyp2a6 inhibitors |
| 09/03/2009 | US20090220603 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/03/2009 | US20090220586 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides |
| 09/03/2009 | US20090220505 Methods of inhibiting amyloid toxicity |
| 09/03/2009 | US20090220460 Virus strains |
| 09/03/2009 | DE19521720B4 Insulinanalogonformulierungen Insulin analog formulations |
| 09/03/2009 | CA2753833A1 Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries |
| 09/03/2009 | CA2716898A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | CA2716893A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 09/03/2009 | CA2716855A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177 |
| 09/03/2009 | CA2716757A1 Kit, composition, product or medicament for treating cognitive impairment |
| 09/03/2009 | CA2716747A1 Gamma secretase modulators for the treatment of alzheimer's disease |
| 09/03/2009 | CA2716613A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 09/03/2009 | CA2716405A1 Combinations for treating hiv-associated pain |
| 09/03/2009 | CA2716109A1 Heteroaryl derivatives as cftr modulators |
| 09/03/2009 | CA2716095A1 Steroid analogues for neuroprotection |
| 09/03/2009 | CA2714573A1 Indazole derivatives |
| 09/03/2009 | CA2714058A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/03/2009 | CA2713776A1 New macrolides and their use |
| 09/03/2009 | CA2710996A1 5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h-cyclopropa[a]naphtalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde used as drugs |
| 09/03/2009 | CA2710962A1 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereef and therapeutic application thereof |
| 09/03/2009 | CA2710943A1 Derivatives of n-phenyl-imidazo[1,2-.alpha.]pyridine-2-carboxamides, preon thereof and therapeutic application thereof |
| 09/03/2009 | CA2710860A1 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2710794A1 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2-.alpha.]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |